Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2013 07:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Appoints Yong Sun as VP Strategic Marketing and Business Development

Nearly 20 Years Marketing Experience to Bolster Company's Future Expansion Into Asia and Emerging Markets Second New Global Position Adds Depth to Company's International Growth...
October 23, 2013 07:00 ET | Source: Harvard Bioscience, Inc.

Five-Year Follow-Up of World's First Regenerated Trachea Transplant Published in The Lancet

HOLLISTON, Mass., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) and Harvard Apparatus Regenerative Technology (Nasdaq:HARTV) jointly announce that five years after a...
October 22, 2013 15:40 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience, Inc. Schedules Third Quarter 2013 Conference Call for October 31, 2013 at 11:00 AM ET

HOLLISTON, Mass., Oct. 22, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and...
October 21, 2013 07:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Appoints Yoav Sibony as VP Global Sales

HOLLISTON, Mass., Oct. 21, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research...
October 16, 2013 07:10 ET | Source: Harvard Bioscience, Inc.

HBIO Announces Details of Approved Spin-Off of Harvard Apparatus Regenerative Technology, Inc.

HOLLISTON, Mass., Oct. 16, 2013 (GLOBE NEWSWIRE) -- The Board of Directors of Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to...
October 16, 2013 07:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Names Robert E. Gagnon as Chief Financial Officer

HOLLISTON, Mass., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research...
September 24, 2013 17:53 ET | Source: Harvard Bioscience, Inc.

HBIO Subsidiary Harvard Apparatus Regenerative Technology, Inc. Files Amendment to Its Form 10 Registration Statement for Planned Spin-Off

HOLLISTON, Mass., Sept. 24, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research...
August 27, 2013 11:11 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Jeffrey A. Duchemin as New CEO

HOLLISTON, Mass., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research...
August 01, 2013 07:00 ET | Source: Harvard Bioscience, Inc.

HBIO Reports Second Quarter 2013 Results

HOLLISTON, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and...
July 31, 2013 18:33 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience, Inc. Schedules Second Quarter 2013 Conference Call for August 1, 2013

HOLLISTON, Mass., July 31, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life...